Indeed, by down-regulation of Parkin in MCF7 using specific shRNA, we were able to rescue the levels of both COXII and COXIV following DXR treatment, indicating that Parkin is a crucial actor in mediating the degradation of mitochondria following DXR treatment in BC cells (Fig. 3B). Here, PRKN is linked to breast cancer.